Genomic profile analysis revealed various genomic mutations in primary breast tumors, including those of PIK3CA, AKT1, estrogen receptor 1 (ESR1), and checkpoint kinase 2, and more frequent mutations in metastatic lesions [22]. Here, ESR1 is linked to breast neoplasm.